PPT-Global Portfolio of Antimalarial Medicines

Translational Product development Access Advanced Nonclinical Patient confirmatory ApprovedERP Human volunteers Patient exploratory Regulatory review MMV048 Artefenomel Ferroquine Sanofi. Use of counterfeit medicines can result in treatment failure or even death Public confidence in healthdelivery syst ems may be eroded following use andor detection of counterfeit medicines Both branded and generic products are subj ect to counterfei Concept and Process. IPC Meeting. June 6, 2014 – WHO Geneva. Nicola Magrini – WHO, EMP. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs. Ezenduka Charles. 1. , . Okonta. Mathew. 2. , . Ekwunife. Obinna. 2. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus. Azusa Sato. London School of Economics, UK. Introduction. Traditional medicines (TM)/healers: WHO. ‘the knowledge, skills and practices based on the theories, beliefs and experiences indigenous to different cultures, used in the maintenance of health and in the prevention, diagnosis, improvement or treatment of physical and mental illness’. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Presented By:. . Payal. . Mondal. . Priyadarshini. . K.. . Prachi. . Gaikwad. . Pratik. . Gada. . retail . market between 1999 and 2009: a comparison between Brazil and Mexico . Authors:. Rene Soria-Saucedo. 1. , Veronika J. Wirtz. 1. , Warren A. Kaplan. 2. Institutions: . 1. Center for Health Systems Research, National Institute of Public Health, Mexico; . for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Translational. Product development. Access. Preclinical. Patient confirmatory. Approved/ERP. Human volunteers. Patient exploratory. Regulatory review. MMV048. MMV. Artefenomel. /. Ferroquine. Sanofi. imidazolidinedione. derivatives. Anna . Jaromin. . 1,*. ,. Anna Czopek . 2. ,. Agnieszka . Zagórska. . 2. , Silvia . Parapini. . 3. , Nicoletta . Basilico. . 4. , . Jerzy Gubernator. . 1. 1. Chloroquine (Aralen™) What is chloroquine? Chloroquine (also known as chloroquine phosphate) is an antimalarial medicine. It is available in the United States by prescription only. It is sold By the end of this lecture you will be able to:. Recognize malaria life cycle & its varied clinical presentation. Classify . antimalarial. drugs. Identify the pharmacokinetic, dynamics, related to each drug.